Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.82 |
| ▸ | MAPT | P10636 | 4/20 | 0.82 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.82 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.82 |
| ▸ | HPGD | P15428 | 3/20 | 0.78 |
| ▸ | LMNA | P02545 | 2/20 | 0.78 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.78 |
| ▸ | MEN1 | O00255 | 1/20 | 0.78 |
| ▸ | HTT | P42858 | 1/20 | 0.78 |
| ▸ | ALOX5 | P09917 | 5/20 | 0.65 |
| ▸ | TOP2A | P11388 | 1/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.48 |
| ▸ | TP53 | P04637 | 1/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | EDNRB | P24530 | 4/20 | 0.47 |
| ▸ | EDNRA | P25101 | 2/20 | 0.47 |
| ▸ | PDE1A | P54750 | 2/20 | 0.46 |
| ▸ | PDE1B | Q01064 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Justicidin A SCHEMBL30368670 | 1.00 | ALDH1A1 (0.82) | ALDH1A1MAPTKDM4ENPSR1HPGD | |
| Justicidin A SCHEMBL29731045 | 1.00 | ALDH1A1 (0.82) | ALDH1A1MAPTKDM4ENPSR1HPGD | |
| Taiwanin E Methyl Ether SCHEMBL30637589 | 0.95 | MAPT (0.74) | ALDH1A1MAPTKDM4ENPSR1HPGD | |
| Taiwanin E Methyl Ether SCHEMBL11954034 | 0.95 | MAPT (0.74) | ALDH1A1MAPTKDM4ENPSR1HPGD | |
| SCHEMBL18812556 | 0.93 | MAPT (0.75) | ALDH1A1MAPTKDM4ENPSR1HPGD | |
| Chinensinaphthol Methyl Ether SCHEMBL30471940 | 0.92 | KDM4E (0.70) | ALDH1A1MAPTKDM4ENPSR1HPGD | |
| Chinensinaphthol Methyl Ether SCHEMBL30471865 | 0.92 | KDM4E (0.70) | ALDH1A1MAPTKDM4ENPSR1HPGD | |
| Neojusticin B SCHEMBL30190318 | 0.91 | ALDH1A1 (0.72) | ALDH1A1MAPTKDM4ENPSR1HPGD | |
| Neojusticin B SCHEMBL30471811 | 0.91 | ALDH1A1 (0.72) | ALDH1A1MAPTKDM4ENPSR1HPGD | |
| Neojusticin B SCHEMBL15920775 | 0.91 | ALDH1A1 (0.72) | ALDH1A1MAPTKDM4ENPSR1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 811 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4674894-A2 | COPOLYMERS OF N-VINYLPYRROLIDONE WITH FUNCTIONALIZED MALEIC ACID MOIETIES | Hemoteq AG (DE) | 2026-01-07 | — | — | EP | claimed |
| EP-4663688-A2 | CROSSLINKERS | Hemoteq AG (DE) | 2025-12-17 | — | — | EP | claimed |
| US-11167065-B2 | Shellac and paclitaxel coated catheter balloons | EUROCOR TECH GMBH (DE) | 2021-11-09 | — | — | US | claimed |
| US-10869904-B2 | Pharmaceutical composition for preventing or treating respiratory disease comprising extract of Justicia procumbens L | DONG WHA PHARM. CO., LTD. (KR) | 2020-12-22 | — | — | US | claimed |
| EP-3485920-B1 | COATING METHOD FOR A FOLDED BALLOON | BRAUN MELSUNGEN AG (DE) | 2020-05-20 | — | — | EP | claimed |
| US-20190275211-A1 | SHELLAC AND PACLITAXEL COATED CATHETER BALLOONS | EUROCOR TECH GMBH (DE) | 2019-09-12 | — | — | US | claimed |
| CN-106957309-B | The preparation method of lignanoids monomer in a kind of justicia | 山东省分析测试中心 | 2019-07-30 | — | — | CN | claimed |
| EP-3485920-A1 | COATING METHOD FOR A FOLDED BALLOON | B. Braun Melsungen AG (DE) | 2019-05-22 | — | — | EP | claimed |
| CN-109731206-A | A kind of sacculus for biological body vessel bifurcated lesions and application thereof and operation method | 中国医学科学院阜外医院 | 2019-05-10 | — | — | CN | claimed |
| US-20190134126-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING RESPIRATORY DISEASE COMPRISING EXTRACT OF JUSTICIA PROCUMBENS L. | DONG WHA PHARM. CO., LTD. (KR) | 2019-05-09 | — | — | US | claimed |
| US-20050176678-A1 | Oligosaccharide or polysaccharide which contain sugar segments; antiproliferative agents; antiinflammatory agents; anticoagulants | HEMOTEQ AG (DE) | 2005-08-11 | — | — | US | claimed |
| US-20050129731-A1 | Biocompatible, biostable coating of medical surfaces | HEMOTEQ AG (DE) | 2005-06-16 | — | — | US | claimed |
| WO-2005032611-A2 | BIOCOMPATIBLE, BIOSTABLE COATING OF MEDICAL SURFACES | HEMOTEQ GMBH (DE) | 2005-04-14 | — | — | WO | claimed |
| US-20050060028-A1 | Blood biocompatible layer and adjacent layer containing antiproliferative, antiinflammatory and/or antithrombotic active agent covalently and/or adhesively bound | HEMOTEQ AG (DE) | 2005-03-17 | — | — | US | claimed |
| EP-1501565-A1 | COMPOUNDS AND METHOD FOR COATING SURFACES IN A HAEMOCOMPATIBLE MANNER | Hemoteq GmbH (DE) | 2005-02-02 | — | — | EP | claimed |
| CN-1568166-A | Coated stent for preventing restenosis | HEMOTEQ GMBH (DE) | 2005-01-19 | — | — | CN | claimed |
| EP-1435877-A1 | COATING OF STENTS FOR PREVENTING RESTENOSIS | Hemoteq GmbH (DE) | 2004-07-14 | — | — | EP | claimed |
| WO-2003094990-A1 | COMPOUNDS AND METHOD FOR COATING SURFACES IN A HAEMOCOMPATIBLE MANNER | HEMOTEQ GMBH (DE) | 2003-11-20 | — | — | WO | claimed |
| EP-1336602-A1 | Nitrate prodrugs able to release nitric oxide in a controlled and selective way and their use for prevention and treatment of inflammatory, ischemic and proliferative diseases | Scaramuzzino, Giovanni (IT) | 2003-08-20 | — | — | EP | claimed |
| WO-2003034944-A1 | COATING OF STENTS FOR PREVENTING RESTENOSIS | HEMOTEQ GMBH (DE) | 2003-05-01 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050176678-A1 | Oligosaccharide or polysaccharide which contain sugar segments; antiproliferative agents; antiinflammatory agents; anticoagulants | FUT5, CSGALNACT1, FUT6 | ALDH1A1 2008/4885MAPT 4877/4885KDM4E 3618/4885 |
| US-20050129731-A1 | Biocompatible, biostable coating of medical surfaces | MSR1, CD44, PIGS | ALDH1A1 2298/4885MAPT 4641/4885KDM4E 4418/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.